The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions

被引：0
|
作者：
Afshar-Oromieh, A. [1 ]
Hetzheim, H. [2 ]
Kratochwil, C. [1 ]
Benesova, M. [3 ]
Eder, M. [4 ]
Neels, O.
Kuebler, W. [5 ]
Giesel, F. L. [1 ]
Mier, W. [6 ]
Kopka, K. [4 ]
Haberkorn, U. [1 ]
机构：
[1] Univ Heidelberg Hosp, Heidelberg, Germany
[2] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany
[3] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
[4] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
[5] German Canc Res Ctr, Div Radiat Protect & Dosimetry, Heidelberg, Germany
[6] Univ Heidelberg Hosp, Div Radiochem, Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP429
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [21] Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
    A. Afshar-Oromieh
    A. Malcher
    M. Eder
    M. Eisenhut
    H. G. Linhart
    B. A. Hadaschik
    T. Holland-Letz
    F. L. Giesel
    C. Kratochwil
    S. Haufe
    U. Haberkorn
    C. M. Zechmann
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 971 - 972
  • [22] Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
    Afshar-Oromieh, A.
    Malcher, A.
    Eder, M.
    Eisenhut, M.
    Linhart, H. G.
    Hadaschik, B. A.
    Holland-Letz, T.
    Giesel, F. L.
    Kratochwil, C.
    Haufe, S.
    Haberkorn, U.
    Zechmann, C. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (06) : 971 - 972
  • [23] PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions (vol 40, pg 486, 2013)
    Afshar-Oromieh, A.
    Malcher, A.
    Eder, M.
    Eisenhut, M.
    Linhart, H. G.
    Hadaschik, B. A.
    Holland-Letz, T.
    Giesel, F. L.
    Kratochwil, C.
    Haufe, S.
    Haberkorn, U.
    Zechmann, C. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (05) : 797 - 798
  • [24] THE DIAGNOSTIC VALUE OF 68GA-LABELLED PSMA-LIGAND PET/CT IN MEN WITH RECURRENT PROSTATE CANCER
    Hadaschik, Boris
    Afshar-Oromieh, Ali
    Radtke, Jan
    Boxler, Silvan
    Eder, Matthias
    Kopka, Klaus
    Debus, Juergen
    Hohenfellner, Markus
    Haberkorn, Uwe
    JOURNAL OF UROLOGY, 2015, 193 (04): : E638 - E638
  • [25] Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
    Cordula A. Jilg
    Kathrin Reichel
    Christian Stoykow
    H. Christian Rischke
    Mark Bartholomä
    Vanessa Drendel
    Moritz von Büren
    Wolfgang Schultze-Seemann
    Philipp T. Meyer
    Michael Mix
    EJNMMI Research, 10
  • [26] Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer
    Melanie Hohberg
    Carsten Kobe
    Philipp Krapf
    Philipp Täger
    Jochen Hammes
    Felix Dietlein
    Boris D. Zlatopolskiy
    Heike Endepols
    Markus Wild
    Stephan Neubauer
    Axel Heidenreich
    Bernd Neumaier
    Alexander Drzezga
    Markus Dietlein
    EJNMMI Research, 9
  • [27] Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer
    Hohberg, Melanie
    Kobe, Carsten
    Krapf, Philipp
    Taeger, Philipp
    Hammes, Jochen
    Dietlein, Felix
    Zlatopolskiy, Boris D.
    Endepolst, Heike
    Wild, Markus
    Neubauer, Stephan
    Heidenreich, Axel
    Neumaier, Bernd
    Drzezga, Alexander
    Dietlein, Markus
    EJNMMI RESEARCH, 2019, 9 (1)
  • [28] Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
    Jilg, Cordula A.
    Reichel, Kathrin
    Stoykow, Christian
    Rischke, H. Christian
    Bartholomae, Mark
    Drendel, Vanessa
    von Bueren, Moritz
    Schultze-Seemann, Wolfgang
    Meyer, Philipp T.
    Mix, Michael
    EJNMMI RESEARCH, 2020, 10 (01)
  • [29] F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
    Frederik L. Giesel
    B. Hadaschik
    J. Cardinale
    J. Radtke
    M. Vinsensia
    W. Lehnert
    C. Kesch
    Y. Tolstov
    S. Singer
    N. Grabe
    S. Duensing
    M. Schäfer
    O. C. Neels
    W. Mier
    U. Haberkorn
    K. Kopka
    C. Kratochwil
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 678 - 688
  • [30] F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
    Giesel, Frederik L.
    Hadaschik, B.
    Cardinale, J.
    Radtke, J.
    Vinsensia, M.
    Lehnert, W.
    Kesch, C.
    Tolstov, Y.
    Singer, S.
    Grabe, N.
    Duensing, S.
    Schaefer, M.
    Neels, O. C.
    Mier, W.
    Haberkorn, U.
    Kopka, K.
    Kratochwil, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (04) : 678 - 688
12345